Monoclonal Antibody Development
Leinco Technologies offers over 25 years of demonstrated success in monoclonal antibody development for demanding applications such as early discovery research, in vivo preclinical therapeutic investigations, and in vitro diagnostics. Capabilities include antibodies developed in mice or Armenian hamsters against soluble proteins, cell surface molecules, or haptens for use in detection, neutralization or in vivo depletion. Utilizing proprietary development technologies, our scientific staff is skilled at producing monoclonal antibodies against single amino acid substitutions, splice variants and for neutralization.
Superior mAb Performance Using Mice or Hamsters
Leinco Technologies uniquely offers monoclonal antibody development using both mice or hamsters as host animals. Importantly, the use of hamster as the host animal offers the unique advantage of producing antibodies that can be used in vivo in mouse models without eliciting an immune response against the injected antibody.
Benefits of Partnering with Leinco
Communication with clients is of essential importance to quality monoclonal antibody development processes at Leinco Technologies . Our team of antibody experts can handle complex projects specific to clients’ needs while ensuring project goals are met.
We provide our clients with:
- Real-time project status reports
- Strong confidentiality and secure project management system
- Teleconferences discussing project data and proceeding steps
- Quick and consistent results
- Summary of all project phases
Let’s Discuss Your Project
Phases of Hybridoma Cell Line Development
Hybridoma cell line development consists of four (4) phases including immunization, fusion, cloning and in vitro antibody production. A protein or peptide-based project typically requires 4 – 6 mg of soluble antigen. Upon successful development of a panel of stable hybridoma cell lines, further characterization of secreted monoclonal antibodies and small-scale production is completed. In addition, at the conclusion of each project clients receive complete documentation of all phases and a development summary.